The FDA's pediatric drug development guidance specifically requires dedicated pediatric pharmacokinetic studies before dosing recommendations can be made for new molecular entities in patients under 18 [16]
Alzheimers prevention deserves better than extrapolation
Semaglutide carries a boxed warning regarding the risk of thyroid C-cell tumors, based on rodent studies showing increased incidence of medullary thyroid carcinoma
For patients at JosephCareRX, Semaglutide GLP-1 offers a dual benefit: not only does it aid in managing blood sugar levels, but it also supports weight loss, an important consideration for individuals who are overweight or obese
Semaglutide and tirzepatide are GLP-1 receptor agonists, meaning they mimic the hormone glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating blood sugar, digestion, and appetite